KK

Kusuma Kiran Gollapalli

Active Director Director DIN 07633371
DIN 07633371 First appointment Dec 2016 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2016
Shareholding value •••• Premium profile

About Kusuma Kiran Gollapalli

Data last updated:

Kusuma Kiran Gollapalli is a Director at Cato Pharmaceuticals Private Limited (since 2016). The company operates in Trading. Cato Pharmaceuticals Private Limited reported revenue of ₹15.3 Lakh (FY 2018).

DIN 07633371
Primary Designation Director
Industry Trading
First Appointment 06 Dec 2016
Oldest Company Age 9 yrs
Largest company Cato Pharmaceuticals Private Limited · ₹15.3 Lakh (FY 2018)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cato Pharmaceuticals Private Limited U51909AP2016PTC104558
Director06 Dec 20162016₹15.3 Lakh (FY 2018)Active

Board colleagues of Kusuma Kiran Gollapalli

Directorship timeline

Open interactive timeline →
Cato Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Kusuma Kiran Gollapalli

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kusuma Kiran Gollapalli

Kusuma Kiran Gollapalli currently holds 1 directorship: Cato Pharmaceuticals Private Limited (Director, since 06 Dec 2016, revenue ₹15.3 Lakh (FY 2018)).

Kusuma Kiran Gollapalli was first appointed on 06 Dec 2016 as Director at Cato Pharmaceuticals Private Limited.

The current boards of Kusuma Kiran Gollapalli's companies include Pasapuleti Veerabhadra Rao (Cato Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available